These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Inhibition of disease progression by a novel retinoid antagonist in animal models of arthritis. Beehler BC, Hei YJ, Chen S, Lupisella JA, Ostrowski J, Starrett JE, Tortolani D, Tramposch KM, Reczek PR. J Rheumatol; 2003 Feb; 30(2):355-63. PubMed ID: 12563696 [Abstract] [Full Text] [Related]
10. Efficacy of sustained blood levels of interleukin-1 receptor antagonist in animal models of arthritis: comparison of efficacy in animal models with human clinical data. Bendele A, McAbee T, Sennello G, Frazier J, Chlipala E, McCabe D. Arthritis Rheum; 1999 Mar; 42(3):498-506. PubMed ID: 10088773 [Abstract] [Full Text] [Related]
11. Adiponectin mitigates the severity of arthritis in mice with collagen-induced arthritis. Lee SW, Kim JH, Park MC, Park YB, Lee SK. Scand J Rheumatol; 2008 Mar; 37(4):260-8. PubMed ID: 18612926 [Abstract] [Full Text] [Related]
16. Amelioration of accelerated collagen induced arthritis by a novel calcineurin inhibitor, ISA(TX)247. Maksymowych WP, Jhangri GS, Aspeslet L, Abel MD, Trepanier DJ, Naicker S, Freitag DG, Cooper BL, Foster RT, Yatscoff RW. J Rheumatol; 2002 Aug; 29(8):1646-52. PubMed ID: 12180723 [Abstract] [Full Text] [Related]
17. [Inhibition of cartilage destruction in collagen-induced arthritis by altered CII 263-272 peptide: experiment with rats]. Yao ZQ, Zhao JX, Li R, Li ZG. Zhonghua Yi Xue Za Zhi; 2006 Nov 21; 86(43):3055-8. PubMed ID: 17288836 [Abstract] [Full Text] [Related]
18. Combination benefit of treatment with the cytokine inhibitors interleukin-1 receptor antagonist and PEGylated soluble tumor necrosis factor receptor type I in animal models of rheumatoid arthritis. Bendele AM, Chlipala ES, Scherrer J, Frazier J, Sennello G, Rich WJ, Edwards CK. Arthritis Rheum; 2000 Dec 21; 43(12):2648-59. PubMed ID: 11145022 [Abstract] [Full Text] [Related]